Who invested in Perfuse Therapeutics?
Perfuse Therapeutics's investors include OrbiMed.

Funding summaryUpdated 26 Oct 2026
$9.0Mraised across 1 round since 2020, from 1 source
Perfuse Therapeutics's investors include OrbiMed.
Perfuse Therapeutics has raised $9.0M across 1 round since 2020.
Perfuse Therapeutics's most recent round was a Series A of $9.0M in Jul 2020.
Its most recent round, $9.0M in Jul 2020, is also its largest on record.
Perfuse Therapeutics's first round on record, in Jul 2020, was backed by OrbiMed.
Perfuse Therapeutics's latest named round is a Series A, in Jul 2020.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.